Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) Q4 2019 Earnings Conference Call March 12, 2020 8:30 AM ET Company Participants Allen Baharaff - Chairman, CEO & President Yohai Stenzler - CFO & Controller Liat Hayardeny - Chief Scientific Officer Conference Call Participants Yasmeen Rahimi - ROTH Capital Partners Steven Seedhouse - Raymond James Antonio Arce - H.C. Wainwright & Co. Kristen Kluska - Cantor Fitzgerald Jason McCarthy - Maxim Group Operator Good day, and welcome to Galmed’s Fourth Quarter and Full Yea ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring t ...

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) Q3 2019 Earnings Conference Call November 6, 2019 8:30 AM ET Company Participants Allen Baharaff - Chairman, CEO & President Yohai Stenzler - CFO & Controller Liat Hayardeny - Chief Scientific Officer Tali Gorfine - Chief Medical Officer Conference Call Participants Steven Seedhouse - Raymond James & Associates Antonio Arce - H.C. Wainwright & Co. Adam Walsh - Stifel, Nicolaus & Company Paul O'Brien - Roth Capital Mayank Mamtani - B. Riley FBR, Inc. Kristen Kluska - ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q2 2019 Earnings Conference Call August 5, 2019 8:30 AM ET Company Participants Allen Baharaff - President and Chief Executive Officer Yohai Stenzler - Chief Financial Officer Tali Gorfine - Chief Medical Officer Liat Hayardeny - Chief Scientific Officer Conference Call Participants Yasmeen Rahimi - Roth Capital Partners Adam Walsh - Stifel Steve Seedhouse - Raymond James Ed Arce - H.C. Wainwright Mayank Mamtani - B. Riley FBR Operator Good day, and welcome to the G ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Allen Baharaff - President & Chief Executive Officer Liat Hayardeny - Chief Scientific Officer Tali Gorfine - Chief Medical Officer Yohai Stenzler - Chief Financial Officer Conference Call Participants Steve Seedhouse - Raymond James Mayank Mamtani - B. Riley Thomas Yip - H.C Operator Good day, and welcome to the Galmed Conference Call to discuss Financial Results for the First Quarter of 2 ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q4 2018 Results Earnings Conference Call March 13, 2019 8:30 AM ET Company Participants Paul Arndt - Managing Director, LifeSci Advisors Allen Baharaff - Co-Founder, President, Chief Executive Officer Liat Hayardeny - Chief Scientific Officer Tali Gorfine - Chief Medical Officer Yohai Stenzler - Chief Financial Officer Conference Call Participants Steven Seedhouse - Raymond James Adam Walsh - Stifel Ed Arce - H.C. Wainwright Mayank Mamtani - B. Riley Caroline Palome ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring t ...